Literature DB >> 7060131

Structure of the active nucleolar chromatin of Xenopus laevis Oocytes.

P Labhart, T Koller.   

Abstract

Active nucleolar chromatin of Xenopus laevis oocytes was prepared for electron microscopy by a step gradient method, which separates the chromatin from proteins and other constituents that might nonspecifically bind at low ionic strength. Between putative RNA polymerases and within the nontranscribed spacer region, the chromatin appears as smooth, thin filaments. For the first time, it is shown here that these filaments are indistinguishable from pure DNA absorbed to the same specimen, even when the ionic strength is raised up to 100 mM NaCl. Bulk rat liver chromatin, however, which was coprepared as a biochemically well-characterized standard with the active nucleolar chromatin, shows nucleosomes containing fibers, which condense into supranucleosomal structures with increasing ionic strength. Since the appearance and the behavior of active nucleolar chromatin at different ionic strengths and pHs resembles tht of pure DNA, but not of any known type of chromatin, it is suggested that, except for the transcription apparatus, very few macromolecular constituents are associated with ribosomal DNA during transcription. The observations described in this paper explain most of the published and partly conflicting results obtained by electron microscopy of nucleolar chromatin.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7060131     DOI: 10.1016/0092-8674(82)90346-4

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  13 in total

1.  Structural analysis of mouse rDNA: coincidence between nuclease hypersensitive sites, DNA curvature and regulatory elements in the intergenic spacer.

Authors:  G Längst; T Schätz; J Langowski; I Grummt
Journal:  Nucleic Acids Res       Date:  1997-02-01       Impact factor: 16.971

2.  The integrity of the histone-DNA complex in chromatin fibres is not necessary for the maintenance of the shape of mitotic chromosomes.

Authors:  H Homberger; T Koller
Journal:  Chromosoma       Date:  1988       Impact factor: 4.316

3.  Transcription of adenovirus 2 major late and peptide IX genes under conditions of in vitro nucleosome assembly.

Authors:  T Matsui
Journal:  Mol Cell Biol       Date:  1987-04       Impact factor: 4.272

4.  Dynamics of interaction of RNA polymerase II with nucleosomes. II. During read-through and elongation.

Authors:  P Bhargava
Journal:  Protein Sci       Date:  1993-12       Impact factor: 6.725

5.  Comparative studies on the structural organization of membrane-depleted nuclei and metaphase chromosomes.

Authors:  H Wunderli; M Westphal; B Armbruster; P Labhart
Journal:  Chromosoma       Date:  1983       Impact factor: 4.316

6.  Primary organization of nucleosomal core particles is invariable in repressed and active nuclei from animal, plant and yeast cells.

Authors:  S G Bavykin; S I Usachenko; A I Lishanskaya; V V Shick; A V Belyavsky; I M Undritsov; A A Strokov; I A Zalenskaya; A D Mirzabekov
Journal:  Nucleic Acids Res       Date:  1985-05-24       Impact factor: 16.971

7.  The enhancers and promoters of the Xenopus laevis ribosomal spacer are associated with histones upon active transcription of the ribosomal genes.

Authors:  S I Dimitrov; L Karagyozov; D Angelov; I G Pashev
Journal:  Nucleic Acids Res       Date:  1990-11-11       Impact factor: 16.971

8.  Compact structure of ribosomal chromatin in Xenopus laevis.

Authors:  C Spadafora; M Crippa
Journal:  Nucleic Acids Res       Date:  1984-03-26       Impact factor: 16.971

9.  A structural concept for nucleoli of Dictyostelium discoideum deduced from dissociation studies.

Authors:  P Labhart; E Banz; P J Ness; R W Parish; T Koller
Journal:  Chromosoma       Date:  1984       Impact factor: 4.316

10.  Different chromatin structures along the spacers flanking active and inactive Xenopus rRNA genes.

Authors:  R Lucchini; J M Sogo
Journal:  Mol Cell Biol       Date:  1992-10       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.